Association of capillary density and function measures with blood pressure, fasting plasma glucose, and insulin

Cynthia Cheng1, Constantine Daskalakis, Bonita Falkner

  • 1Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. cynthia.cheng@jefferson.edu

Insights

Reduced capillary density and function are linked to higher systolic blood pressure but do not explain the connection between hypertension and insulin resistance.

Area of Science:

  • Cardiovascular science
  • Metabolic research
  • Vascular biology

Background:

  • The link between hypertension and insulin resistance is not fully understood.
  • Capillary abnormalities may play a role in this association.

Purpose of the Study:

  • To investigate if reduced capillary density or function explains the hypertension-insulin resistance link.
  • To analyze the relationship between capillaroscopy measures, blood pressure, and insulin sensitivity.

Main Methods:

  • Study included 115 adults (18-55 years) with normal or elevated blood pressure.
  • Capillary density and function assessed via capillaroscopy.
  • Insulin sensitivity (IS) measured by Quantitative Insulin Sensitivity Check Index (QUICKI); endothelial function (EF) by strain-gauge plethysmography.
  • Linear regression analysis adjusted for age, sex, race, and BMI.

Main Results:

  • Capillary measures correlated with systolic blood pressure (SBP), fasting plasma glucose, and endothelial function (EF) after BMI adjustment.
  • No significant association found between capillary measures and fasting insulin or IS.
  • Capillary measures were linked to SBP but not insulin resistance.

Conclusions:

  • Capillary density and function are associated with systolic blood pressure, not directly with insulin resistance.
  • Capillary measures are unlikely to explain the link between hypertension and insulin resistance, especially in mild cases.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...